Concepedia

Author

Christoph Wanner

Universitätsklinikum WürzburgORCID

Also Known As

Alan Jardine, Bernard Zinman, C WANNER, C Wanner, C. WANNER, C. Wanner, C., Wanner, CHRISTOPH WANNER, Carsten A Wagner, Carsten Wagner

1.3K

Publications

104.9K

Citations

134

H-Index

240

Concepts

All Affiliations

Universitätsklinikum WürzburgUniversity of WürzburgBoehringer Ingelheim (Germany)Heidelberg UniversityCharité - Universitätsmedizin Berlin
CW

About

Christoph Wanner is an author at Universitätsklinikum Würzburg specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

14

15

993

2

Engineering

4

4

61

3

Management

2

2

96

4

Business

1

1

14

5

Education

1

1

43

Christoph Wanner

×

490

Publications

74.7K

Citations

109

H-Index

YearCitations

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin,

New England Journal of Medicine

2015

11.6K

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L.J. Visseren, François Mach, Yvo M. Smulders,

European Heart Journal

2021

5.8K

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer, Stefan D. Anker, Javed Butler,

New England Journal of Medicine

2020

4.7K

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin,

New England Journal of Medicine

2016

3.5K

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension

Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström,

Journal of Hypertension

2023

2.7K

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

Christoph Wanner, Vera Krane, Winfried März,

New England Journal of Medicine

2005

2.6K

A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

Denis Fouque, Kamyar Kalantar‐Zadeh, Joel D. Kopple,

Kidney International

2007

1.9K

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

Josef Zimmermann, Silke Herrlinger, Antje Pruy,

Kidney International

1999

1.5K

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen,

JAMA

2018

1K

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Dick de Zeeuw, Tadao Akizawa, Paul Audhya,

New England Journal of Medicine

2013

969

Page 1